[Ip-health] Sanofi Halves Price of Cancer Drug Zaltrap After Sloan-Kettering Rejection

Sophie Mayer sophie.emma.mayer at gmail.com
Fri Nov 9 08:51:05 PST 2012

"In an unusual move, a big drug company said on Thursday that it would
effectively cut in half the price of a new
after a leading cancer center said it would not use the drug because
it was too expensive."

Full story here:

Original op-ed by Sloan-Kettering:

More information about the Ip-health mailing list